Biomarin Stock Forecast & Price Target
Biomarin Stock
Price Forecast
The average stock forecast for
Biomarin Pharmaceutical Inc (BMRN) in the next 12 months is 93.30 USD. This price target corresponds to an upside
of
40.44%. The range of stock forecasts for Biomarin is 59.59 - 130.20 USD.
Based on the ratings of 35 analysts, the consensus recommendation for Biomarin is
BUY.
| Target |
Low |
Average |
Median |
High |
| Price (USD) |
59.59 |
93.30 |
91.45 |
130.20 |
| Upside |
-10.30% |
40.44% |
37.67% |
96.00% |
Recommendation Trends
The latest consensus rating for Biomarin is "BUY". This is the average
recommendation of 35 analysts: 0 strong sell,
0 sell, 8 hold, 17 buy, 10 strong buy. In the previous period, 33 analysts also majorly recommmended
"BUY" for Biomarin.
Biomarin Financial Stock
Forecast
Revenue This Year
from 3.22B
Revenue Next Year
from 3.98B